Screening for autism spectrum disorders: state of the art in Europe
Year: 2014
Type: review
Abstract: A large number of studies have reported on the validity of autism spectrum disorder (ASD) screening procedures. An overall understanding of these studies' findings cannot be based solely on the level of internal validity of each, since screening instruments might perform differently according to certain factors in different settings. Europe has led the field with the development of the first screening tool and first prospective screening study of autism. This paper seeks to provide an overview of ASD screening studies and ongoing programmes across Europe, and identify variables that have influenced the outcomes of such studies. Results show that, to date, over 70,000 children have been screened in Europe using 18 different screening procedures. Differences among findings across studies have enabled us to identify ten factors that may influence screening results. Although it is impossible to draw firm conclusions as to which screening procedure is most effective, this analysis might facilitate the choice of a screening method that best fits a specific scenario, and this, in turn, may eventually improve early ASD detection procedures.
Institutions: Instituto de Salud Carlos III, Instituto de Investigación de Enfermedades Raras, Utrecht University, King's College London, Ghent University, Université Toulouse - Jean Jaurès, Fondazione Stella Maris, University Medical Center Utrecht, Oulu University Hospital, Centre for Biomedical Network Research on Rare Diseases, Universidad de Salamanca, Instituto Universitario de Integración en la Comunidad
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $2,990
OpenAlex ID: W2143054164
